@article{Kolesnyk_Dudar_Stepanova_Krasyuk_Gonchar_Loboda_2020, title={Management of acute kidney injury in patients with COVID-19 or CKD stage 1-4 patients with acute kidney injury in the COVID-19 pandemic: Adapted clinical guidelines of the Ukrainian Association of Nephrologists and Kidney Transplant Specialists}, url={https://ukrjnd.com.ua/index.php/journal/article/view/427}, DOI={10.31450/ukrjnd.3(67).2020.04}, abstractNote={<p>Acute kidney injury (AKI) is diagnosed in 1–40% of the COVID-19 patients; from 2% to 10% of the patients are required renal replacement therapy (RRT). The mortality rate in this category of patients reached 88%. Early AKI detection in the patients with COVID-19, followed by the use of preventive and therapeutic measures to minimize the incidence or progression is a significant key to reduce the mortality rate and transformation of AKI into chronic kidney disease (CKD).</p> <p>The expert group of the Ukrainian Association of Nephrologists and Kidney Transplant Specialists has created the adapted clinical guidelines for the management of acute kidney injury in patients with COVID-19 or CKD stage 1-4 patients with acute kidney injury in the COVID-19 pandemic. These guidelines are intended for family physicians, general practitioners, physicians, cardiologists, nephrologists, intensivists, endocrinologists, infectious disease specialists and other professionals involved in the provision of specialized medical care to the patients with COVID-19.</p> <p>Specialized medical care for AKI patients infected COVID-19 should be provided by a multidisciplinary team, which has to involve nephrologists, infectious disease specialists and intensivists.</p&gt;}, number={3(67)}, journal={Ukrainian Journal of Nephrology and Dialysis}, author={Kolesnyk, M. and Dudar, I. and Stepanova, N. and Krasyuk, E. and Gonchar, Yu. and Loboda, O.}, year={2020}, month={Aug.}, pages={20-27} }